163 related articles for article (PubMed ID: 29264488)
1. Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet.
Ng Tang Fui M; Hoermann R; Grossmann M
J Endocr Soc; 2017 Apr; 1(4):302-312. PubMed ID: 29264488
[TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
[TBL] [Abstract][Full Text] [Related]
4. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
Ng Tang Fui M; Hoermann R; Zajac JD; Grossmann M
Clin Endocrinol (Oxf); 2017 Oct; 87(4):336-343. PubMed ID: 28561278
[TBL] [Abstract][Full Text] [Related]
5. Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial.
Ng Tang Fui M; Hoermann R; Nolan B; Clarke M; Zajac JD; Grossmann M
Sci Rep; 2018 Jun; 8(1):9099. PubMed ID: 29904126
[TBL] [Abstract][Full Text] [Related]
6. Fasting gut hormone levels change with modest weight loss in obese adolescents.
Jensen DE; Nguo K; Baxter KA; Cardinal JW; King NA; Ware RS; Truby H; Batch JA
Pediatr Obes; 2015 Oct; 10(5):380-7. PubMed ID: 25559355
[TBL] [Abstract][Full Text] [Related]
7. Long-term persistence of hormonal adaptations to weight loss.
Sumithran P; Prendergast LA; Delbridge E; Purcell K; Shulkes A; Kriketos A; Proietto J
N Engl J Med; 2011 Oct; 365(17):1597-604. PubMed ID: 22029981
[TBL] [Abstract][Full Text] [Related]
8. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.
Hoyos CM; Yee BJ; Phillips CL; Machan EA; Grunstein RR; Liu PY
Eur J Endocrinol; 2012 Oct; 167(4):531-41. PubMed ID: 22848006
[TBL] [Abstract][Full Text] [Related]
9. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
Belinova L; Kahleova H; Malinska H; Topolcan O; Windrichova J; Oliyarnyk O; Kazdova L; Hill M; Pelikanova T
PLoS One; 2017; 12(4):e0174820. PubMed ID: 28369078
[TBL] [Abstract][Full Text] [Related]
10. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
[TBL] [Abstract][Full Text] [Related]
11. Effect of a 4-week weight maintenance diet on circulating hormone levels: implications for clinical weight loss trials.
Sainsbury A; Evans IR; Wood RE; Seimon RV; King NA; Hills AP; Byrne NM
Clin Obes; 2015 Apr; 5(2):79-86. PubMed ID: 25645138
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in the response of plasma leptin concentrations to weight loss in obese older individuals.
Nicklas BJ; Katzel LI; Ryan AS; Dennis KE; Goldberg AP
Obes Res; 1997 Jan; 5(1):62-8. PubMed ID: 9061717
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
Bhasin S; Storer TW; Javanbakht M; Berman N; Yarasheski KE; Phillips J; Dike M; Sinha-Hikim I; Shen R; Hays RD; Beall G
JAMA; 2000 Feb; 283(6):763-70. PubMed ID: 10683055
[TBL] [Abstract][Full Text] [Related]
14. Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Gianatti EJ; Dupuis P; Hoermann R; Zajac JD; Grossmann M
J Clin Endocrinol Metab; 2014 Oct; 99(10):3821-8. PubMed ID: 24978674
[TBL] [Abstract][Full Text] [Related]
15. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
Ozata M; Oktenli C; Bingol N; Ozdemir IC
Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.
Haluzíková D; Lacinová Z; Kaválková P; Drápalová J; Křížová J; Bártlová M; Mráz M; Petr T; Vítek L; Kasalický M; Haluzík M
Obesity (Silver Spring); 2013 Jul; 21(7):1335-42. PubMed ID: 23670968
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP
Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149
[TBL] [Abstract][Full Text] [Related]
19. Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet.
Shetty GK; Matarese G; Magkos F; Moon HS; Liu X; Brennan AM; Mylvaganam G; Sykoutri D; Depaoli AM; Mantzoros CS
Eur J Endocrinol; 2011 Aug; 165(2):249-54. PubMed ID: 21602313
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
